Petros Pharmaceuticals, Inc. Earnings Per Share Diluted

Quick Answer

Petros Pharmaceuticals, Inc. reported Earnings Per Share Diluted of $3.34 (loss) per share for the year ending 2024.

  • Petros Pharmaceuticals, Inc. showed an increase of +47.4% in Earnings Per Share Diluted from 2023 to 2024.
  • This data is from Petros Pharmaceuticals, Inc.'s annual report (Form 10-K), filed with the SEC on March 31, 2025.
  • XBRL data for this metric is available from 2020 to 2024 (5 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 5 years of available data (2020 to 2024), Petros Pharmaceuticals, Inc.'s Earnings Per Share Diluted has grown by 13.2%.
  • Historical annual values: Fiscal year 2024: $3.34 (loss) per share | Fiscal year 2023: $6.35 (loss) per share | Fiscal year 2022: $9.68 (loss) per share | Fiscal year 2021: $8.25 (loss) per share | Fiscal year 2020: $3.85 (loss) per share.
  • Data sourced from SEC EDGAR public filings as of June 22, 2026.

Last verified: